Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06920758 · ClinicalTrials.gov registry record · NA
A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.
A NA study of Thinning Hair, sponsored by Ablon Skin Institute Research Center.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06920758 is a NA study of Thinning Hair that is active but no longer recruiting, run by Ablon Skin Institute Research Center. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06920758, a NA study of Thinning Hair, is active but no longer recruiting, sponsored by Ablon Skin Institute Research Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to substantiate the effectiveness and safety of USPlus® DERM for self-perceived thinning hair compared to placebo in healthy men and women ages 25-65 over the course of six months of continued use. Participants will be asked to have attend three office visits, one phone call, have photos taken of their hair and answer questionnaires related to their thinning hair.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT USPlus DERM Bioactive Fatty Acids 160 mg Softgels
- OTHER Placebo softgel
Study Locations (1)
California
- Ablon Skin Institute and Research Center - Manhattan Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2025-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06920758
The ClinicalTrials.gov registry entry for NCT06920758 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ablon Skin Institute Research Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thinning Hair appearing as the primary indexed condition, and to 2 interventions - of which USPlus DERM Bioactive Fatty Acids 160 mg Softgels is the first listed.
NCT06920758 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06920758 about?
NCT06920758 is a clinical study titled "A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.". The goal of this clinical trial is to substantiate the effectiveness and safety of USPlus® DERM for self-perceived thinning hair compared to placebo in healthy men and women ages 25-65 over the course of six months of continued use. Participants will be asked to have attend three office visits, one ...
What is the current status of trial NCT06920758?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-12-16. Estimated completion is 2025-09.
What conditions does trial NCT06920758 study?
This clinical trial studies the following conditions: Thinning Hair.
What interventions are being tested in trial NCT06920758?
The interventions under investigation include: USPlus DERM Bioactive Fatty Acids 160 mg Softgels (DIETARY_SUPPLEMENT), Placebo softgel (OTHER).
Who is sponsoring clinical trial NCT06920758?
This trial is sponsored by Ablon Skin Institute Research Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06920758 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thinning Hair
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.